Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors.
Raïch I, Rivas-Santisteban R, Lillo A, Lillo J, Reyes-Resina I, Nadal X, Ferreiro-Vera C, de Medina VS, Majellaro M, Sotelo E, Navarro G, Franco R. Raïch I, et al. Among authors: nadal x. Pharmacol Res. 2021 Dec;174:105970. doi: 10.1016/j.phrs.2021.105970. Epub 2021 Nov 7. Pharmacol Res. 2021. PMID: 34758399 Free article.
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.
Navarro G, Varani K, Lillo A, Vincenzi F, Rivas-Santisteban R, Raïch I, Reyes-Resina I, Ferreiro-Vera C, Borea PA, Sánchez de Medina V, Nadal X, Franco R. Navarro G, et al. Among authors: nadal x. Pharmacol Res. 2020 Sep;159:104940. doi: 10.1016/j.phrs.2020.104940. Epub 2020 May 26. Pharmacol Res. 2020. PMID: 32470563
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.
Navarro G, Reyes-Resina I, Rivas-Santisteban R, Sánchez de Medina V, Morales P, Casano S, Ferreiro-Vera C, Lillo A, Aguinaga D, Jagerovic N, Nadal X, Franco R. Navarro G, et al. Among authors: nadal x. Biochem Pharmacol. 2018 Nov;157:148-158. doi: 10.1016/j.bcp.2018.08.046. Epub 2018 Sep 6. Biochem Pharmacol. 2018. PMID: 30194918
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes.
Navarro G, Varani K, Reyes-Resina I, Sánchez de Medina V, Rivas-Santisteban R, Sánchez-Carnerero Callado C, Vincenzi F, Casano S, Ferreiro-Vera C, Canela EI, Borea PA, Nadal X, Franco R. Navarro G, et al. Among authors: nadal x. Front Pharmacol. 2018 Jun 21;9:632. doi: 10.3389/fphar.2018.00632. eCollection 2018. Front Pharmacol. 2018. PMID: 29977202 Free PMC article.
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
Nadal X, Del Río C, Casano S, Palomares B, Ferreiro-Vera C, Navarrete C, Sánchez-Carnerero C, Cantarero I, Bellido ML, Meyer S, Morello G, Appendino G, Muñoz E. Nadal X, et al. Br J Pharmacol. 2017 Dec;174(23):4263-4276. doi: 10.1111/bph.14019. Epub 2017 Nov 2. Br J Pharmacol. 2017. PMID: 28853159 Free PMC article.
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors.
Martínez-Pinilla E, Varani K, Reyes-Resina I, Angelats E, Vincenzi F, Ferreiro-Vera C, Oyarzabal J, Canela EI, Lanciego JL, Nadal X, Navarro G, Borea PA, Franco R. Martínez-Pinilla E, et al. Among authors: nadal x. Front Pharmacol. 2017 Oct 23;8:744. doi: 10.3389/fphar.2017.00744. eCollection 2017. Front Pharmacol. 2017. PMID: 29109685 Free PMC article.
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids.
Franco R, Rivas-Santisteban R, Reyes-Resina I, Casanovas M, Pérez-Olives C, Ferreiro-Vera C, Navarro G, Sánchez de Medina V, Nadal X. Franco R, et al. Among authors: nadal x. Pharmacol Res. 2020 May 13;158:104801. doi: 10.1016/j.phrs.2020.104801. Online ahead of print. Pharmacol Res. 2020. PMID: 32416215 Review.
21 results